Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NYSE - Delayed Quote USD

Stryker Corporation (SYK)

Compare
364.50
-3.04
(-0.83%)
At close: March 28 at 4:00:02 PM EDT
365.00
+0.50
+(0.14%)
After hours: March 28 at 7:49:19 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
22,595,000
22,595,000
20,498,000
18,449,000
17,108,000
Cost of Revenue
8,155,000
8,155,000
7,440,000
6,871,000
6,140,000
Gross Profit
14,440,000
14,440,000
13,058,000
11,578,000
10,968,000
Operating Expense
9,774,000
9,774,000
9,134,000
8,467,000
8,281,000
Operating Income
4,666,000
4,666,000
3,924,000
3,111,000
2,687,000
Other Income Expense
-1,174,000
-1,174,000
-251,000
-428,000
-406,000
Pretax Income
3,492,000
3,492,000
3,673,000
2,683,000
2,281,000
Tax Provision
499,000
499,000
508,000
325,000
287,000
Net Income Common Stockholders
2,993,000
2,993,000
3,165,000
2,358,000
1,994,000
Diluted NI Available to Com Stockholders
2,993,000
2,993,000
3,165,000
2,358,000
1,994,000
Basic EPS
7.86
--
8.34
6.23
5.29
Diluted EPS
7.76
--
8.25
6.17
5.21
Basic Average Shares
381,000
--
379,600
378,200
377,000
Diluted Average Shares
385,600
--
383,700
382,200
382,300
Total Operating Income as Reported
3,689,000
3,689,000
3,888,000
2,841,000
2,584,000
Total Expenses
17,929,000
17,929,000
16,574,000
15,338,000
14,421,000
Net Income from Continuing & Discontinued Operation
2,993,000
2,993,000
3,165,000
2,358,000
1,994,000
Normalized Income
3,830,289
3,830,289
3,196,032
2,595,330
2,084,022
EBIT
4,666,000
4,666,000
3,924,000
3,111,000
2,687,000
EBITDA
5,716,000
5,716,000
4,952,000
4,109,000
3,677,000
Reconciled Cost of Revenue
7,728,000
7,728,000
7,047,000
6,500,000
5,769,000
Reconciled Depreciation
1,050,000
1,050,000
1,028,000
998,000
990,000
Net Income from Continuing Operation Net Minority Interest
2,993,000
2,993,000
3,165,000
2,358,000
1,994,000
Total Unusual Items Excluding Goodwill
-977,000
-977,000
-36,000
-270,000
-103,000
Total Unusual Items
-977,000
-977,000
-36,000
-270,000
-103,000
Normalized EBITDA
6,693,000
6,693,000
4,988,000
4,379,000
3,780,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-139,711
-139,711
-4,968
-32,670
-12,978
12/31/2021 - 3/17/1980

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BSX Boston Scientific Corporation
99.36
-1.43%
 
MDT Medtronic plc
87.63
-0.74%
 
ZBH Zimmer Biomet Holdings, Inc.
112.26
+0.10%
 
EW Edwards Lifesciences Corporation
70.91
-0.39%
 
ABT Abbott Laboratories
130.82
-0.40%
 
DXCM DexCom, Inc.
67.74
-2.49%
 
STE STERIS plc
223.00
-0.55%
 
GMED Globus Medical, Inc.
72.55
-1.51%
 
SNN Smith & Nephew plc
28.05
+0.36%
 
PHG Koninklijke Philips N.V.
25.64
-0.19%